Naylor G M, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A
Chesterfield Royal Hospital, Chesterfield, N Derbyshire S44 5BL, UK.
Gut. 2006 Nov;55(11):1545-52. doi: 10.1136/gut.2005.080358. Epub 2006 Apr 7.
The incidence of gastric cancer in Japan is four times higher than in the UK. It usually arises in a stomach with corpus predominant or pangastritis that has undergone extensive atrophy and intestinal metaplasia. We hypothesised that a Japanese population would have a more severe gastritis with a corpus predominant or pangastritis pattern and a greater degree of atrophy and intestinal metaplasia than that found in the UK. To test this we designed a comparative trial.
A total of 252 age matched consecutive patients were recruited from the endoscopy services in Leeds and Tokyo. In each centre, 21 patients were prospectively selected from each decennial, between the ages of 20-80 years. All had epigastric discomfort as their predominant symptom. Patients with peptic ulcer, cancer, and oesophagitis were excluded. Five gastric biopsies were examined by two histopathologists using the updated Sydney system. Helicobacter pylori infection was assessed by histology and culture of biopsies and enzyme linked immunosorbent assay and immunoblot of plasma.
Gastritis was found by both pathologists in 59 (47%) UK and 76 (60%) Japanese patients (chi(2) test, p = 0.04). In those patients with gastritis, corpus predominant or pangastritis was commoner in the Japanese (63% Japan v 36% in the UK (chi(2) test, p = 0.003) Atrophy and intestinal metaplasia were more extensive and severe (Mann-Whitney U test, p<0.001) and chronic inflammation and polymorph activity were also greater, especially in the corpus (Mann-Whitney U test, p<0.001). Fifty three of 59 UK gastritis patients (90%) and 67/76 (88%) (chi(2) test, p = 1) Japanese gastritis patients were positive for H pylori. Using a previously described "gastric cancer risk index" among H pylori positive patients, there were significantly more Japanese than UK subjects with a "high risk" score.
In Japanese as opposed to English patients, gastritis is more prevalent and severe with more corpus predominant atrophy and intestinal metaplasia. These differences may partially explain the higher incidence of gastric cancer in Japan.
日本胃癌发病率比英国高四倍。胃癌通常发生于胃体为主型或全胃炎且伴有广泛萎缩和肠化生的胃部。我们推测,与英国人群相比,日本人群的胃体为主型或全胃炎模式的胃炎更为严重,萎缩和肠化生程度更高。为验证这一点,我们设计了一项对比试验。
从利兹和东京的内镜检查服务中招募了总共252名年龄匹配的连续患者。在每个中心,从20至80岁的每十年年龄段中前瞻性地选取21名患者。所有患者均以上腹部不适为主要症状。排除患有消化性溃疡、癌症和食管炎的患者。两名组织病理学家使用更新后的悉尼系统对五份胃活检标本进行检查。通过活检标本的组织学和培养以及血浆的酶联免疫吸附测定和免疫印迹评估幽门螺杆菌感染情况。
两位病理学家均发现59名(47%)英国患者和76名(60%)日本患者患有胃炎(卡方检验,p = 0.04)。在这些患有胃炎的患者中,胃体为主型或全胃炎在日本患者中更为常见(日本为63%,英国为36%,卡方检验,p = 0.003)。萎缩和肠化生更广泛且更严重(曼-惠特尼U检验,p<0.001),慢性炎症和多形核细胞活性也更高,尤其是在胃体部(曼-惠特尼U检验,p<0.001)。59名英国胃炎患者中有53名(90%)和76名日本胃炎患者中有67名(88%)幽门螺杆菌检测呈阳性(卡方检验,p = 1)。在幽门螺杆菌阳性患者中,使用先前描述的“胃癌风险指数”,日本“高风险”评分的受试者明显多于英国。
与英国患者相比,日本患者的胃炎更普遍且更严重,胃体为主型萎缩和肠化生更多。这些差异可能部分解释了日本胃癌发病率较高的原因。